GlassScriptPhysician profile
Alan R Deroy
NPI 1184680043
$3,707.39
in general payments reported to CMS, 2019-2025
26 companies · $92.44 in 2025
The $92.44 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $1,676 · 2021: $313 · 2022: $477 · 2023: $328 · 2024: $303 · 2025: $92.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $722.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $1,538.87 | 2020 | |
| Horizon Therapeutics Plc | $255.62 | 2019-2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $254.96 | 2021-2024 | Nuzyra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $164.17 | 2019-2023 | Jublia |
| Triad Life Sciences INC. | $161.56 | 2022 | |
| Bioventus LLC | $146.69 | 2022-2024 | Exogen Ultrasound Bone Healing System |
| Nevro Corp. | $145.68 | 2023 | Senza |
| Tactile Systems Technology INC | $139.49 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Organogenesis INC. | $138.46 | 2019-2023 | Puraply |
| Medtronic, INC. | $126.50 | 2023-2024 | Intellis Adaptivestim |
| Smith+Nephew, INC. | $85.89 | 2021-2022 | |
| Musculoskeletal Transplant Foundation INC. | $78.11 | 2019 | |
| Stryker Corporation | $73.14 | 2022 | |
| Osteomed LLC | $68.27 | 2019-2020 | |
| Globus Medical, INC. | $60.95 | 2025 | Senza |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $43.42 | 2019 | |
| Convatec INC. | $33.88 | 2023 | |
| Biowound Solutions, INC. | $31.49 | 2025 | Bio-Connekt |
| Ossio INC | $29.17 | 2022 | |
| Amgen INC. | $26.66 | 2024 | Krystexxa |
| Sebela Pharmaceuticals INC. | $26.00 | 2019-2022 | |
| Kerecis Limited | $21.56 | 2022 | |
| Hartmann USA, INC. | $17.40 | 2021 | |
| Integra Lifesciences Corporation | $13.95 | 2020 | |
| Avanos Medical | $13.03 | 2021 | |
| Merck Sharp & Dohme LLC | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Deroy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.